Saturday, November 22, 2008

ADHD Home>
ADHD News>
Maker of Vyvanse wants med approved for adults

Maker of Vyvanse wants med approved for adults

(United Press International) UPDATED 2007-06-29

Shire, the maker of Vyvanse, has filed for U.S. approval to treat adult attention-deficit/hyperactivity disorder with their new ADHD medication. Currently the product is approved for children ages 6 to 12 years with ADHD. The company says it has had positive results in their studies treating adults. Read full story >

See all ADHD News

Related: Vicodin

Bookmark

Was this helpful? Yes

Save to My Home
Want to keep this page handy for later? Click Save to My Home and we'll add it to your My Home area.

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on ADHDCentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2008. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.